Conceivable Life Sciences Inc. — Form D/A
Conceivable Life Sciences Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2025-01-02. The offering totals $18.0M, of which $16.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2025-01-02
- Form: D/A
- Accession: 0001013594-25-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $18.0M
- Amount sold: $16.0M
- Remaining: $2.0M
- Investors: 18
- Date of first sale: 2024-11-22
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-532415
Issuer
- Name: Conceivable Life Sciences Inc.
- CIK: 0001986248
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 160 MERCER STREET, NEW YORK, NY, 10012
- Phone: 917-657-2175
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Joshua Abram | Director | New York, NY |
| Joshua Abram | Executive Officer | New York, NY |
| Alan Murray | Director | Irving, TX |
| Alan Murray | Executive Officer | Irving, TX |
| Alex Christ | Director | New York, NY |
| Alejandro Chavez-Badiola | Director | Mexico City, O5 |
| Alejandro Chavez-Badiola | Executive Officer | Mexico City, O5 |
| Stuart Peterson | Director | San Francisco, CA |
| Aike Ho | Director | San Francisco, CA |
| Fred Destin | Director | London, X0 |
Other filings by this issuer (3)
More